Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Sphingosine 1-Phosphate Receptor Modulators [MoA]: Side Effects & Safety Data for 6 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Sphingosine 1-Phosphate Receptor Modulators [MoA] includes 6 drugs with a combined 89,146 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

6
Drugs in Class
89,146
Combined Reports

All Sphingosine 1-Phosphate Receptor Modulators [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
FINGOLIMOD Fingolimod 70,944 1,007 9,066 1.4%
SIPONIMOD MAYZENT 8,581 196 1,396 2.3%
OZANIMOD ZEPOSIA 7-Day Starter Pack 7,894 85 702 1.1%
ETRASIMOD ARGININE Velsipity 1,229 2 78 0.2%
PONESIMOD PONVORY 309 1 33 0.3%
FINGOLIMOD LAURYL TASCENSO ODT 189 3 13 1.6%

Common Side Effects in Sphingosine 1-Phosphate Receptor Modulators [MoA] Drugs

Side EffectReportsDeaths
Fatigue 10,666 38
Multiple sclerosis relapse 7,817 57
Headache 7,451 30
Dizziness 5,393 19
White blood cell count decreased 3,971 15
Lymphocyte count decreased 3,745 33
Drug ineffective 3,736 19
Gait disturbance 3,636 25
Hypoaesthesia 3,634 14
Fall 3,364 25
View detailed side effects for this class → Compare drugs in this class →